aepi.org
Friday PiDay — Georgia Brothers For Life Take on Crohn's & Colitis | AEPi
This is a first-person, local-profile story showing how people with IBD support each other and work with the Crohn’s & Colitis Foundation to fund research and resources. It highlights real-world experiences with symptoms, treatments, and surgery that others with IBD may relate to.
Adult patients with Crohn’s disease or ulcerative colitis; caregivers and family members; people interested in IBD advocacy and fundraising.
What To Know
This article is a personal profile of three longtime fraternity brothers who live with Crohn’s disease and ulcerative colitis and who are volunteering with the Crohn’s & Colitis Foundation’s Georgia Torch Gala to raise funds for research.
It describes their diagnoses, treatments in broad terms (oral medication), symptoms they experienced (pain, weight loss, joint issues), at least one colonoscopy, and that one brother had a full colectomy and multiple surgeries. The piece emphasizes peer support, fundraising, and advocacy rather than new clinical findings.
Mark, Neal, and David are longtime friends who share experiences with IBD and are active volunteers for the Crohn’s & Colitis Foundation’s Torch Gala in Georgia. The story includes personal experiences with diagnosis, symptom struggles, use of oral medications, and surgical treatment (a full colectomy) for one brother.
Their involvement focuses on fundraising for research, clinical trials, education, and advocacy; the article cites the Foundation’s 2025 fundraising goal for the Torch Gala. The piece is a human-interest profile intended to raise awareness and support, not to report new medical evidence or treatment guidance.
Adult patients with Crohn’s disease or ulcerative colitis, caregivers and family members, and people interested in patient advocacy or fundraising for IBD research.
This is a patient-story/profile and fundraiser piece, not a clinical study. It reports individual experiences (including surgery and use of oral medications) and describes involvement with the Crohn’s & Colitis Foundation; it does not provide new research data or treatment recommendations.
